Engaging Indigenous Organizations to Sustain and Enhance Comprehensive Clinical Services for the Prevention, Care and Treatment of HIV/AIDS in the Federal Republic of Nigeria under the President’s Emergency Plan for AIDS Relief (PEPFAR) | Apply Online

Frequently Asked Questions (FAQs)

What is the title of this funding opportunity?

The opportunity is titled "Engaging Indigenous Organizations to Sustain and Enhance Comprehensive Clinical Services for the Prevention, Care and Treatment of HIV/AIDS in the Federal Republic of Nigeria under the President's Emergency Plan for AIDS Relief (PEPFAR)."

Which agency is offering this opportunity?

This is a cooperative agreement administered by the U.S. Department of Health and Human Services, Centers for Disease Control and Prevention (HHS-CDC).

What type of funding mechanism is this?

The funding instrument is a cooperative agreement (not a standard grant), which typically means substantial involvement by CDC in implementation, oversight, and technical collaboration during the project period.

What is the main purpose of this opportunity?

The purpose is to sustain and strengthen comprehensive clinical HIV services in Nigeria, while also enhancing the quality, reach, and durability of those services by engaging indigenous (in-country) organizations and building local leadership and implementation capacity.

What country is the program focused on?

The program focus is the Federal Republic of Nigeria.

How does this opportunity relate to PEPFAR?

The opportunity is explicitly under the President's Emergency Plan for AIDS Relief (PEPFAR) and is aimed at maintaining continuity of essential HIV prevention, care, and treatment services supported through that initiative, while improving and strengthening delivery through local partners.

What program area or category does this opportunity fall under?

It sits within the health funding activity category and is associated with CDC global HIV/AIDS and related public health efforts.

What is the CFDA number associated with this opportunity?

The associated CFDA number is 93.067.

What is the opportunity number?

The opportunity number is CDC RFA GH12-121005CONT16.

Is this a new competition or a continuation action?

It is explicitly categorized as a "Continuation" opportunity. That typically indicates it is connected to ongoing programming and is intended to continue or expand previously funded activities or maintain existing cooperative agreement structures, rather than being a brand-new open competition.

When was this opportunity posted?

The opportunity was posted on January 27, 2016 (and created the same day).

What was the application closing date?

The application closing date was March 28, 2016.

What does "comprehensive clinical services" mean in the context of this opportunity?

Based on the description provided, "comprehensive clinical services" implies a broad approach across the HIV care continuum in clinical settings. This can include sustaining and strengthening services such as HIV testing and linkage to care, antiretroviral therapy (ART) initiation and retention, viral load monitoring and viral suppression efforts, prevention services integrated into clinical settings, and broader patient-centered clinical care for people living with HIV. It also implies attention to clinical systems that support long-term treatment effectiveness, such as adherence support, patient tracking, laboratory integration, and quality improvement in health facilities.

What types of HIV-related activities are typically supported under this kind of award?

The description suggests support for activities along the clinical HIV service continuum, including: HIV testing and linkage to care; ART initiation and retention; viral load monitoring and efforts to increase viral suppression; prevention services integrated into clinical care; and systems that improve ongoing care such as adherence support, patient tracking, lab integration, and quality improvement approaches within facilities.

Why does the opportunity emphasize engaging indigenous organizations?

The emphasis reflects an intent to promote in-country leadership and implementation capacity so HIV services are not only maintained, but become more durable and locally led over time. The description notes that this aligns with broader PEPFAR goals related to country ownership, local capacity building, and transitioning implementation responsibilities to local partners where feasible.

Who is eligible to apply?

Eligibility is listed as "Others," with a note indicating applicants should consult the specific eligibility clarification in the full announcement text. Based on the title and description, the opportunity is intended to promote the role of Nigerian indigenous organizations, which commonly includes local non-governmental organizations, local faith-based or community-based implementers, and sometimes local academic or clinical institutions positioned to lead service delivery.

What does CDC involvement look like under a cooperative agreement?

Because this is a cooperative agreement, applicants are generally expected to work closely with CDC technical staff on program strategy, performance monitoring, alignment with PEPFAR priorities, and reporting requirements. The description also signals typical expectations around data quality, monitoring and evaluation, and continuous performance improvement in large-scale HIV programs.

What kinds of performance areas are commonly emphasized in CDC/PEPFAR cooperative agreements?

The description highlights a strong focus on targets and outcomes central to HIV program accountability. Examples mentioned include numbers tested, numbers on ART, retention rates, and viral suppression, along with expectations related to data quality, monitoring and evaluation, and continuous performance improvement.

Is the expected number of awards stated in the information provided?

No. The expected number of awards is not specified in the provided information.

Is there a published award ceiling for this opportunity?

The award ceiling is shown as 0 in the provided summary information. This commonly indicates that a ceiling was not set in the public synopsis field or that budget specifics would be defined elsewhere (for example, in the full funding announcement or continuation guidance).

How are budgets typically determined for opportunities like this?

In many CDC/PEPFAR contexts described here, budgets may be determined based on program scope, target coverage, geographic focus, and performance, rather than a single fixed maximum amount listed in the synopsis.

What is the overall goal of this continuation opportunity?

The overall goal is to keep HIV prevention, care, and treatment services stable in Nigeria while improving them, with a strong push toward engaging and empowering indigenous organizations to implement comprehensive clinical HIV programming, supported through close CDC collaboration typical of cooperative agreements.